Therapeutic Asset Ratings

303 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Abemaciclib Digestive System Neuroendocrine Tumor, Grade 1/2	University of Washington	P2	CCC (53)
Abemaciclib Foregut Neuroendocrine Tumor	University of Washington	P2	CCC (53)
Abemaciclib Hindgut Neuroendocrine Tumor	University of Washington	P2	CCC (53)
Abemaciclib Midgut Neuroendocrine Tumor	University of Washington	P2	CCC (53)
Abemaciclib Pancreatic Neuroendocrine Tumor	University of Washington	P2	CCC (53)
ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT) Recurrent B Lymphoblastic Lymphoma	University of Washington	P2	CCC (53)
ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT) Refractory B Lymphoblastic Lymphoma	University of Washington	P2	CCC (53)
c105 Non-Small Cell Lung Carcinoma	University of Washington	P2	CCC (53)
c105 Hormone Receptor-Positive Breast Cancer	University of Washington	P2	CCC (53)
c105 Triple-Negative Breast Carcinoma	University of Washington	P2	CCC (53)
c105 Lung Cancer	University of Washington	P2	CCC (53)
cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine Non-Small Cell Lung Carcinoma	University of Washington	P2	CCC (53)
cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine Hormone Receptor-Positive Breast Cancer	University of Washington	P2	CCC (53)
cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine Triple-Negative Breast Carcinoma	University of Washington	P2	CCC (53)
cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine Lung Cancer	University of Washington	P2	CCC (53)
Cytosin-Arabinosid EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified	University of Washington	P2	CCC (53)
Cytosin-Arabinosid T-Cell/Histiocyte-Rich Large B-Cell Lymphoma	University of Washington	P2	CCC (53)
Cytosin-Arabinosid Transformed B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma to Diffuse Large B-Ce	University of Washington	P2	CCC (53)
Decitabine Myeloproliferative Neoplasm, Unclassifiable	University of Washington	P2	CCC (53)
DEXAMETHASONE Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma	University of Washington	P2	CCC (53)
Epcoritamab Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma Of The Elderly	University of Washington	P2	CCC (53)
Epcoritamab High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement	University of Washington	P2	CCC (53)
Epcoritamab T-Cell/Histiocyte Rich Large B Cell Lymphoma	University of Washington	P2	CCC (53)
Epcoritamab B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma And Classical Hodgkin Lymphoma	University of Washington	P2	CCC (53)
ETOPOSIDE B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1	University of Washington	P2	CCC (53)

Showing 151 to 175 of 303 assets

PreviousPage 7 of 13Next